MedPath
HSA Approval

VELSIPITY FILM-COATED TABLET 2 MG

SIN17015P

VELSIPITY FILM-COATED TABLET 2 MG

VELSIPITY FILM-COATED TABLET 2 MG

May 30, 2024

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L04AE05

Manufacturer Information

PFIZER PRIVATE LIMITED

Penn Pharmaceutical Services Limited

Active Ingredients

Etrasimod L-arginine eqv Etrasimod

2 mg

Etrasimod

Documents

Package Inserts

Velsipity Approved PI.pdf

Approved: May 30, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VELSIPITY FILM-COATED TABLET 2 MG - HSA Approval | MedPath